Info

The NACCHO Podcast Series

The NACCHO Podcast series provides public health professionals with in-depth interviews featuring some of the field's top officials. Listeners can also learn the latest news from Washington, DC with our monthly "Podcast From Washington."
RSS Feed Subscribe in Apple Podcasts
The NACCHO Podcast Series
2024
November
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
February


2022
December
October
September
June
May
April
March
February
January


2021
December
November
October
September
July
June
May
April
March
February
January


2020
December
November
October
September
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Apr 29, 2021

In this week’s episode of Podcast from Washington, NACCHO government affairs team members Ian Goldstein and Eli Briggs discuss President Biden’s first address to Congress. They also discuss the FDA decision to prohibit the sale of menthol flavors in tobacco products, and the Biden Administration’s latest guidelines for medication-assisted treatment.

Later in the program, Ian speaks with Dr. Nisha Nataraj, a statistician on the  Applied Research, Evaluation, and Integration team in the Division of Overdose Prevention at the CDC, and Dr. Mark Roberts, professor of Health Policy and Management at the University of Pittsburgh. They discuss their collaborative effort to build the Framework for Reconstructing Epidemiologic Dynamics (FRED) simulator for opioid use disorder and overdose, and how local health departments can use the FRED tool to simulate the disease progression of prescription and illicit opioid use disorder.

0 Comments
Adding comments is not available at this time.